Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
Abstract
ABSTRACT Luteolin (LUT) has been suggested as an inhibitor of osteoporosis (OP). This investigation examines the pivotal role of the miR‐125b‐5p/SIRT3/AMPK/mTOR pathway in mediating luteolin‐induced effects on OP. Mesenchymal stem cells derived from bone marrow (BMSCs) were exposed to dexamethasone (DEX) to create an in vitro model of OP. Following treatment with luteolin, the levels of miR‐125b‐5p and SIRT3 were quantified using reverse transcription polymerase chain reaction. Moreover, SIRT3, AMPK, mTOR protein levels, and osteogenesis (OPN, Runx2, OSX, and OCN), and autophagy (p62, ATG5, LC3, and BECN1) were evaluated using ELISA. Additionally, specific mimics and siRNA were constructed to overexpress miR‐125b‐5p or downregulate SIRT3. Furthermore, animal models of DEX‐induced OP were constructed to assess the effects of LUT at doses of 50 and 100 mg/kg/day on bone histology, stereology, biochemistry, and the expression of the miR‐125b‐5p, SIRT3/AMPK/mTOR axis, and markers of osteogenesis and autophagy. The findings revealed that LUT suppressed miR‐125b‐5p expression, overexpressed SIRT3 and AMPK, and downregulated mTOR in BMSCs compared to DEX (p‐value < 0.01). Interestingly, LUT restored the levels of markers for osteogenesis and autophagy (p‐value < 0.001). The overexpression of SIRT3 or miR‐125b‐5p downregulation inhibited LUT therapeutic properties. In animals, LUT improved bone histology (p‐value < 0.05) and inhibited miR‐125b‐5p and mTOR expression while…
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
- Efficacy and Safety of Lemborexant for Insomnia Patients With Nocturia—A Prospective Study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.